Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738

Detalles Bibliográficos
Autores principales: Checkley, Stephen, MacCallum, Linda, Yates, James, Jasper, Paul, Luo, Haobin, Tolsma, John, Bendtsen, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747154/
https://www.ncbi.nlm.nih.gov/pubmed/26859465
http://dx.doi.org/10.1038/srep16545
_version_ 1782414925051723776
author Checkley, Stephen
MacCallum, Linda
Yates, James
Jasper, Paul
Luo, Haobin
Tolsma, John
Bendtsen, Claus
author_facet Checkley, Stephen
MacCallum, Linda
Yates, James
Jasper, Paul
Luo, Haobin
Tolsma, John
Bendtsen, Claus
author_sort Checkley, Stephen
collection PubMed
description
format Online
Article
Text
id pubmed-4747154
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47471542016-02-17 Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738 Checkley, Stephen MacCallum, Linda Yates, James Jasper, Paul Luo, Haobin Tolsma, John Bendtsen, Claus Sci Rep Corrigenda Nature Publishing Group 2016-02-09 /pmc/articles/PMC4747154/ /pubmed/26859465 http://dx.doi.org/10.1038/srep16545 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigenda
Checkley, Stephen
MacCallum, Linda
Yates, James
Jasper, Paul
Luo, Haobin
Tolsma, John
Bendtsen, Claus
Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title_full Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title_fullStr Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title_full_unstemmed Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title_short Corrigendum: Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
title_sort corrigendum: bridging the gap between in vitro and in vivo: dose and schedule predictions for the atr inhibitor azd6738
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747154/
https://www.ncbi.nlm.nih.gov/pubmed/26859465
http://dx.doi.org/10.1038/srep16545
work_keys_str_mv AT checkleystephen corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT maccallumlinda corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT yatesjames corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT jasperpaul corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT luohaobin corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT tolsmajohn corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738
AT bendtsenclaus corrigendumbridgingthegapbetweeninvitroandinvivodoseandschedulepredictionsfortheatrinhibitorazd6738

Ejemplares similares